Contraceptive Pills Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of Contraceptive Pills Market

The contraceptive pills market size was valued at USD 13.11 billion in 2018, and the market is now projected tgrow from USD 29.04 billion by 2032, exhibiting a CAGR of 5.9% during the forecast period of 2019-2026.

Government attempts tlimit population growth are helping people gain knowledge on birth control and spacing. Huge numbers of unwanted pregnancies make consumers in developed markets seek contraceptive pills. However, there is little doubt that high population density in Asia is creating serious socioeconomic problems. Government as well as private organizations are supporting education about sexual relations and the use of contraception. These factors drive the contraceptive pills market growth.

People in both urban and rural areas are using contraceptive pills at an increasing rate based on awareness. This trend is being boosted by increased public and private efforts towards making sex education more accessible tthe population. They are all contributing tpromoting and expanding the utilization of contraceptive pills. The contraceptive pills market share is improving because of these developments. This growth is anticipated tsustain as consciousness of the product and its availability increases.

Comprehensive Analysis of Contraceptive Pills Market

The contraceptive pills market and healthcare industry is rising at an exponential rate due tits market segmentation. This market expansion effectively provides a detailed regional assessments considering the dominant supply and demand forces that impact the healthcare industry. These segmentations are methodically segregated by Types, by Distribution Channels. The type includes, Combination Pills and Progestin-only Pills. The distribution channel includes, Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGO, and Others.

North America is projected taccount for more than 50% of the market in terms of revenue, with USD 4.09 billion generated in 2018, mainly due tthe growing popularity of short-acting reversible contraception in the United States and the implementation of favourable reimbursement policies. The CDC alsestimates reports that 64.9% of all the women in the United States between 15-49 years of age used contraception between the years 2015 and 2017. Of them, 12.6% chose oral contraceptive pills as their preferred contraceptive method. Thus, the high popularity of hormonal contraceptives, particularly in the United States, affected the market growth. This trend is thought tremain unchanged and be supported by favourable policies.

The top players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include, Pfizer, Inc., Merck & Co., Inc., Teva Pharmaceutical Industries, Allergan, plc, Bayer AG, Janssen Pharmaceutical Company, HLL Lifecare Limited, Mylan N.V. and Piramal Enterprises. These market players provide a level-playing competitive landscape.

In April 2018, Mylan N.V. introduced Drospirenone and Ethinyl Estradiol Tablets intthe United States market as a generic equivalent tBayer’s Yaz. Women recommend the use of the tablet for the prevention of pregnancy and acne vulgaris in women.

Segmentation Table

Global Industrial Cybersecurity Market Scope

Study Period 2015-2026

Base Year 2018

Forecast Period 2019-2026

Growth Rate CAGR of 5.9% from 2019 t2026

Historical Period 2015-2017

Unit Value (USD Billion)

Segmentation By Type, Distribution Channel, and Geography

By Type

Combines Contraceptives Pills

Progestin-only Pills

By Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Clinics

Online Channel

Public Channel & NGOs

Others

By Geography

North America (U.S. and Canada)

Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia-Pacific)

Latin America (Brazil, Mexico, and Rest of Latin America)

Middle East and Africa ( South Africa, GCC, and Rest of Middle East & Africa)


1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. 4.1 Fertility Statistics (2018)
4.2. 4.2 Regulatory scenario for key countries
4.3. 4.3 Recent industry developments such as mergers & acquisitions
4.4. 4.4 Key Industry Trends
4.5. 4.5 Government policies & their impact on contraceptives industry
4.6. 4.6 New Product Launches
5. Global Contraceptive Pills Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Type
5.3. 5.2.1 Combined Contraceptives (E+P)
5.4. 5.2.2 Progestin-only Pills
5.5. Market Analysis, Insights and Forecast – By Distribution Channel
5.6. 5.3.1 Hospital Pharmacy
5.7. 5.3.2 Retail Pharmacy
5.8. 5.3.3 Clinics
5.9. 5.3.4 Online Channel
5.10. 5.3.5 Public Channel & NGOs
5.11. 5.3.6 Others
5.12. Market Analysis, Insights and Forecast – By Region
5.13. 5.4.1 North America
5.14. 5.4.2 Europe
5.15. 5.4.3 Asia pacific
5.16. 5.4.4 Latin America
5.17. 5.4.5 Middle East & Africa
6. North America Contraceptive Pills Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis – By Type
6.3. 6.2.1 Combined Contraceptives (E+P)
6.4. 6.2.2 Progestin-only Pills
6.5. Market Analysis – By Distribution Channel
6.6. 6.3.1 Hospital Pharmacy
6.7. 6.3.2 Retail Pharmacy
6.8. 6.3.3 Clinics
6.9. 6.3.4 Online Channel
6.10. 6.3.5 Public Channel & NGOs
6.11. 6.3.6 Others
6.12. Market Analysis – By Country
6.13. 6.4.1 U.S.
6.14. 6.4.2 Canada
7. Europe Contraceptive Pills Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis – By Type
7.3. 7.2.1 Combined Contraceptives (E+P)
7.4. 7.2.2 Progestin-only Pills
7.5. Market Analysis – By Distribution Channel
7.6. 7.3.1 Hospital Pharmacy
7.7. 7.3.2 Retail Pharmacy
7.8. 7.3.3 Clinics
7.9. 7.3.4 Online Channel
7.10. 7.3.5 Public Channel & NGOs
7.11. 7.3.6 Others
7.12. Market Analysis – By Country/Sub-region
7.13. 7.4.1 U.K.
7.14. 7.4.2 Germany
7.15. 7.4.3 France
7.16. 7.4.4 Spain
7.17. 7.4.5 Italy
7.18. 7.4.6 Scandinavia
7.19. 7.4.7 Rest of Europe
8. Asia pacific Contraceptive Pills Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis – By Type
8.3. 8.2.1 Combined Contraceptives (E+P)
8.4. 8.2.2 Progestin-only Pills
8.5. Market Analysis – By Distribution Channel
8.6. 8.3.1 Hospital Pharmacy
8.7. 8.3.2 Retail Pharmacy
8.8. 8.3.3 Clinics
8.9. 8.3.4 Online Channel
8.10. 8.3.5 Public Channel & NGOs
8.11. 8.3.6 Others
8.12. Market Analysis – By Country/Sub-region
8.13. 8.4.1 Japan
8.14. 8.4.2 China
8.15. 8.4.3 India
8.16. 8.4.4 Australia
8.17. 8.4.5 Southeast Asia
8.18. 8.4.6 Rest of Asia Pacific
9. Latin America Contraceptive Pills Market Analysis, Insights and Forecast, 2015-2026
9.1. Key Findings / Summary
9.2. Market Analysis – By Type
9.3. 9.2.1 Combined Contraceptives (E+P)
9.4. 9.2.2 Progestin-only Pills
9.5. Market Analysis – By Distribution Channel
9.6. 9.3.1 Hospital Pharmacy
9.7. 9.3.2 Retail Pharmacy
9.8. 9.3.3 Clinics
9.9. 9.3.4 Online Channel
9.10. 9.3.5 Public Channel & NGOs
9.11. 9.3.6 Others
9.12. Market Analysis – By Country/Sub-region
9.13. 9.4.1 Brazil
9.14. 9.4.2 Mexico
9.15. 9.4.3 Rest of Latin America
10. Middle East & Africa Contraceptive Pills Market Analysis, Insights and Forecast, 2015-2026
10.1. Key Findings / Summary
10.2. Market Analysis – By Type
10.3. 10.2.1 Combined Contraceptives (E+P)
10.4. 10.2.2 Progestin-only Pills
10.5. Market Analysis – By Distribution Channel
10.6. 10.3.1 Hospital Pharmacy
10.7. 10.3.2 Retail Pharmacy
10.8. 10.3.3 Clinics
10.9. 10.3.4 Online Channel
10.10. 10.3.5 Public Channel & NGOs
10.11. 10.3.6 Others
10.12. Market Analysis – By Country/Sub-region
10.13. 10.4.1 GCC Countries
10.14. 10.4.2 South Africa
10.15. 10.4.3 Rest of Middle East & Africa
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2018)
11.3. Competition Dashboard
11.4. Comparative Analysis – Major Players
11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
11.5.1. Allergan plc
11.5.1.1. Overview,
11.5.1.2. Products & services,
11.5.1.3. SWOT analysis,
11.5.1.4. Recent developments,
11.5.1.5. strategies,
11.5.1.6. financials (based on availability)
11.5.2. Pfizer, Inc
11.5.2.1. Overview,
11.5.2.2. Products & services,
11.5.2.3. SWOT analysis,
11.5.2.4. Recent developments,
11.5.2.5. strategies,
11.5.2.6. financials (based on availability)
11.5.3. Merck & Co., Inc.
11.5.3.1. Overview,
11.5.3.2. Products & services,
11.5.3.3. SWOT analysis,
11.5.3.4. Recent developments,
11.5.3.5. strategies,
11.5.3.6. financials (based on availability)
11.5.4. Teva Pharmaceutical Industries
11.5.4.1. Overview,
11.5.4.2. Products & services,
11.5.4.3. SWOT analysis,
11.5.4.4. Recent developments,
11.5.4.5. strategies,
11.5.4.6. financials (based on availability)
11.5.5. Bayer AG
11.5.5.1. Overview,
11.5.5.2. Products & services,
11.5.5.3. SWOT analysis,
11.5.5.4. Recent developments,
11.5.5.5. strategies,
11.5.5.6. financials (based on availability)
11.5.6. Janssen Pharmaceutical Company
11.5.6.1. Overview,
11.5.6.2. Products & services,
11.5.6.3. SWOT analysis,
11.5.6.4. Recent developments,
11.5.6.5. strategies,
11.5.6.6. financials (based on availability)
11.5.7. HLL Lifecare Limited
11.5.7.1. Overview,
11.5.7.2. Products & services,
11.5.7.3. SWOT analysis,
11.5.7.4. Recent developments,
11.5.7.5. strategies,
11.5.7.6. financials (based on availability)
11.5.8. Mylan N.V.
11.5.8.1. Overview,
11.5.8.2. Products & services,
11.5.8.3. SWOT analysis,
11.5.8.4. Recent developments,
11.5.8.5. strategies,
11.5.8.6. financials (based on availability)
11.5.9. Piramal Enterprises
11.5.9.1. Overview,
11.5.9.2. Products & services,
11.5.9.3. SWOT analysis,
11.5.9.4. Recent developments,
11.5.9.5. strategies,
11.5.9.6. financials (based on availability)
12. Strategic Recommendations
"

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings